FIELD: medicine, therapy.
SUBSTANCE: invention can be used to predict and prioritize drug targets for diseases based on a disease-specific graph using machine learning methods. A graph of protein-protein interactions is created, in which nodes are protein-coding genes, edges are interactions of protein-coding genes. A disease-specific graph is created based on the graph of protein-protein interactions by adding nodes of diseases and drug targets and the following links to the graph: protein-coding gene — disease, protein-coding gene — drug target, disease — drug target, disease-disease. The marking of nodes and the construction of graph connections are carried out using disease-specific information. With the help of convolutional neural networks, the resulting graph is convolved into a vector representation. The obtained vector representation of the disease-specific graph is fed into the trained machine learning model for predicting and prioritizing drug targets and a ranked list of protein-coding genes is obtained in terms of the probability of being a drug target for diseases.
EFFECT: method provides accurate prediction of the probability of protein-coding genes to be drug targets for diseases, accelerates the process of identifying drug targets for diseases, and accelerates the development of new effective drugs by automatically ranking the list of protein-coding genes in terms of the probability of being a drug target for diseases with using machine learning methods based on a disease-specific graph.
5 cl, 5 dwg, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DEVELOPING BIOMARKERS OF DISEASES AND PHYSIOLOGICALLY ACTIVE SUBSTANCES BASED ON EXTENDED VERSION OF THE IPANDA ALGORITHM | 2018 |
|
RU2703534C1 |
METHOD FOR SEARCHING TARGET PROTEINS TRIGGERING PROCESS OF CARCINOGENESIS, IN INDIVIDUAL PATIENT'S TISSUE SAMPLES FOR PURPOSES OF SUBSEQUENT ANTITUMOUR MEDICINAL TREATMENT | 2013 |
|
RU2577107C2 |
ONCOBOX GENETIC INFORMATION ANALYSIS PLATFORM | 2018 |
|
RU2741703C1 |
TREATMENT OF DISEASES RELATED WITH GENE DLG BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT OF DLG GENE | 2011 |
|
RU2611190C2 |
METHOD AND SYSTEMS FOR PREDICTION OF HLA CLASS II-SPECIFIC EPITOPES AND CD4+ T-CELL CHARACTERIZATION | 2019 |
|
RU2826261C2 |
PREVENTIVE OR THERAPEUTIC POLYEPITOPIC ANTI-TUBERCULOSIS VACCINE CONSTRUCTION PROVIDING INDUCTION OF CELLULAR IMMUNE RESPONSE OF CD4+ OR CD8+ T-LYMPHOCYTES | 2011 |
|
RU2539035C2 |
COMPOSITION AND METHOD FOR INHIBITING ACCUMULATION, AGGREGATION AND FORMATION OF TAU PROTEIN COILS | 2020 |
|
RU2818590C1 |
TREATING SIRTIUN 1 (SIRT1)-RELATED DISEASES BY INHIBITON OF NATURAL ANTISENSE TRANSCRIPT | 2009 |
|
RU2551234C2 |
SYPHILIS DIAGNOSTIC TECHNIQUE WITH USING METHOD OF DIRECT PROTEOMIC BLOOD SERUM PROFILING | 2008 |
|
RU2381505C1 |
TREATMENT OF DISEASES ASSOCIATED WITH FRATAXIN (FXN), BY INHIBITING NATURAL ANTISENSE FXN TRANSCRIPT | 2012 |
|
RU2620980C2 |
Authors
Dates
2023-06-28—Published
2022-03-14—Filed